| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |